Solokinase 500000IU Injection
Marketer
Aristo Pharmaceuticals Pvt Ltd
Salt Composition
Urokinase (500000IU)
Overview Solokinase 500000IU Injection
Fibrinolytic therapy with a 500,000 IU dose of Solokinase injection dissolves dangerous blood clots obstructing blood vessels. This treatment is indicated for acute myocardial infarction and is also employed in managing pulmonary embolism and ischemic stroke. Administration requires strict medical oversight; dosage and treatment duration are determined and monitored by a physician to ensure patient stability. Potential adverse effects include nausea, vomiting, injection site hemorrhage, hypersensitivity reactions, and hypotension. Increased bleeding risk is a possibility. Prior to administration, a thorough discussion of benefits and risks will be conducted. Concurrently prescribed medications should be continued as directed. Caution is advised in patients with bleeding disorders, hepatic or renal impairment, or those who are pregnant or lactating. Complete disclosure of all current medications is essential.
Primary Ingredients of Solokinase 500000IU Injection
There is no text provided to rephrase.
Uses of Solokinase 500000IU Injection
Myocardial infarction or blockage of the pulmonary artery
Major Benefits of Solokinase 500000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Solokinase 500000IU Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Solokinase 500000IU Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Solokinase 500000IU Injection works:
Solokinase 500000IU Injection disintegrates damaging blood clots within the circulatory system. This action re-establishes blood circulation to compromised tissue, thus averting tissue necrosis and enhancing patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Solokinase 500000IU Injection lacks established safety data. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The administration of Solokinase 500000IU Injection during pregnancy is typically deemed safe. Preclinical trials using animal models revealed minimal or no negative impacts on fetal development; however, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Solokinase 500000IU Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingNOT RELEVANT
Inappropriate for outpatient use; Solokinase 500000IU Injection is exclusively for hospitalized individuals.
KidneySAFE IF PRESCRIBED
The use of Solokinase 500000IU Injection in patients with kidney disease appears to pose minimal risk. Preliminary evidence indicates dose modification may be unnecessary; however, professional medical advice is essential. Solokinase 500000IU Injection is contraindicated for individuals with severe kidney impairment.
LiverCAUTION
Patients with hepatic impairment should receive Solokinase 500000IU Injection with close monitoring. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Solokinase 500000IU Injection :
Should you forget a Solokinase 500000IU Injection dose, seek medical advice.
Facts to Know About Solokinase 500000IU Injection
| Label | Value |
|---|---|
| Type of Compound | Amino acid and peptide analogs |
| Potential for Dependence | None. |
| Medication Category | HEART |
| Mechanism of Action | Early Thrombolytic Agents |
3,018 People bought this recently